Joseph W Eichenbaum
Icahn School of Medicine at Mount Sinai, USA
Jiujiang Zhu
School of Civil Engineering and Architecture, Wuyi University, China
Mervat N Wahba
The University of Tennessee Health Science Center, USA
Jianqing Zhang
The University of China Agricultural, Beijing
Research Article
Published: May 14, 2024
Abstract: Objective: To Examine P53 And P16 Protein Expression In Patients With Squamous Cell Carcinoma (SCC) Of The Oral Cavity And To Determine The Influence Of Each Protein And Their Association With Survival. Methods: We Immunohistochemically Assessed P53 And P16 Expression On Tumor Sections From 69 Patients With Oral Cavity SCC Treated At Our University Hospital, Between January 2014 And January 2018. Results: Expression Of P53 Was Observed In 69.6% Of The Patients, And Of P16 In 30.4%. A Positive P16 Expression Was Less Commonly Found In The Tongue And/or Floor Of The Mouth (p = 0.0015). Patients With P53-positive Tumors Were 3.2 Times More Likely To Die Of The Disease, Whereas Those With P16-positive Tumors Were 0.7 Times More Likely To Die. Conclusion: According To These Results At Primary Sites, Both P53 And P16 Are Relevant Biomarkers, Where P53 Serves As A Risk Marker And P16 As A Protective Marker In Oral Cavity SCC.
By Jonathan L Sweeney*
View e-Print
By Pitra Ariesta Shinta Dewi*
View e-Print
By Dr. Florian Heesch*
View e-Print.jpg)
.jpg)
By Karin Engelhart Jentzsch*
View e-Print
By Traore-Kissima Abdoulaye
View e-Print
By Abdullah A Alabdulgader
View e-Print
By Mohamed Ali Alhosani*
View e-Print.jpg)
By Safa Eldin Abaza*
View e-Print
a Creative Commons Attribution 4.0 International License. Based on a work at www.irispublishers.com.
Best viewed in
| Privacy Policy
